News
AZTA
26.28
-0.45%
-0.12
Is Azenta (AZTA) Recasting Multiomics Leadership To Sharpen Its Long-Range Platform Strategy?
Simply Wall St · 18h ago
Allspring Common Stock Fund: Q1 2026 Top Contributors And Detractors
Seeking Alpha · 1d ago
Weekly Report: what happened at AZTA last week (0413-0417)?
Weekly Report · 1d ago
A Look At Azenta (AZTA) Valuation As Trey Martin Takes Charge Of The Multiomics Business
Simply Wall St · 3d ago
Azenta (AZTA) Stock Drops 13% After-Hours — What's Happening?
Benzinga · 4d ago
Azenta files Form 3 for President Multiomics William E. Martin III
PUBT · 5d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 5d ago
Should Azenta’s (AZTA) New Multiomics President Reshape Confidence in Its Long-Term Genomics Strategy?
Simply Wall St · 04/13 15:21
Weekly Report: what happened at AZTA last week (0406-0410)?
Weekly Report · 04/13 10:34
Azenta Reshapes Multiomics Leadership and Executive Compensation
TipRanks · 04/07 13:14
Azenta names Trey Martin Multiomics president as Ginger Zhou steps down
Reuters · 04/07 12:15
Press Release: Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Dow Jones · 04/07 12:15
Azenta Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 04/06 16:38
Evercore ISI Group Maintains Outperform on Azenta, Lowers Price Target to $35
Benzinga · 04/06 16:28
Weekly Report: what happened at AZTA last week (0330-0403)?
Weekly Report · 04/06 10:35
Assessing Azenta (AZTA) Valuation After Recent Share Price Rebound And Margin Expansion Hopes
Simply Wall St · 04/05 09:20
Stocks to Watch: PMGC, Azenta
Dow Jones · 04/02 22:50
Azenta Weighs Options After Thelema Fails to Secure Acquisition Financing in Time
Dow Jones · 04/02 20:55
Azenta Faces Delay in B Medical Systems Divestiture
TipRanks · 04/02 20:38
AZENTA INC - AGREEMENT NOT AMENDED OR TERMINATED; COMPANY EVALUATING POTENTIAL PATHS FORWARD - SEC FILING
Reuters · 04/02 20:13
More
Webull provides a variety of real-time AZTA stock news. You can receive the latest news about Azenta Inc through multiple platforms. This information may help you make smarter investment decisions.
About AZTA
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.